Dis-Chem succession enters a new phase

Original Article by Ann Crotty | Financial Mail | 27 August 2026

The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.

Image | Mina Sunflower | Shutterstock/2613011987

The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.

Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.

Discovery’s headline earnings are expected to rise by up to 36%, supported by South African and Vitality growth.